收费全文 | 20709篇 |
免费 | 1207篇 |
国内免费 | 68篇 |
耳鼻咽喉 | 562篇 |
儿科学 | 784篇 |
妇产科学 | 463篇 |
基础医学 | 2445篇 |
口腔科学 | 489篇 |
临床医学 | 1198篇 |
内科学 | 5575篇 |
皮肤病学 | 932篇 |
神经病学 | 1294篇 |
特种医学 | 404篇 |
外科学 | 3197篇 |
综合类 | 159篇 |
预防医学 | 2032篇 |
眼科学 | 399篇 |
药学 | 1109篇 |
中国医学 | 112篇 |
肿瘤学 | 830篇 |
2023年 | 111篇 |
2022年 | 268篇 |
2021年 | 651篇 |
2020年 | 325篇 |
2019年 | 661篇 |
2018年 | 907篇 |
2017年 | 469篇 |
2016年 | 410篇 |
2015年 | 434篇 |
2014年 | 665篇 |
2013年 | 906篇 |
2012年 | 1295篇 |
2011年 | 1372篇 |
2010年 | 914篇 |
2009年 | 731篇 |
2008年 | 1067篇 |
2007年 | 1151篇 |
2006年 | 1182篇 |
2005年 | 1109篇 |
2004年 | 1010篇 |
2003年 | 920篇 |
2002年 | 880篇 |
2001年 | 678篇 |
2000年 | 839篇 |
1999年 | 634篇 |
1998年 | 140篇 |
1997年 | 101篇 |
1996年 | 74篇 |
1995年 | 89篇 |
1994年 | 66篇 |
1993年 | 58篇 |
1992年 | 214篇 |
1991年 | 180篇 |
1990年 | 178篇 |
1989年 | 131篇 |
1988年 | 128篇 |
1987年 | 111篇 |
1986年 | 118篇 |
1985年 | 110篇 |
1984年 | 69篇 |
1983年 | 62篇 |
1979年 | 29篇 |
1974年 | 46篇 |
1973年 | 42篇 |
1972年 | 37篇 |
1971年 | 35篇 |
1970年 | 47篇 |
1969年 | 50篇 |
1968年 | 32篇 |
1967年 | 29篇 |
Background and objectives
A prompt and effective management of trauma patient is necessary. The aim of this case report is to highlight the importance of intraoperative echocardiography as a useful tool in patients suffering from refractory hemodynamic instability no otherwise explained.Case report
A 41 year‐old woman suffered a car accident. At the emergency department, no abnormalities were found in ECG or chest X‐ray. Abdominal ultrasound revealed the presence of abdominal free liquid and the patient was submitted to urgent exploratory laparotomy. Nevertheless, she persisted suffering arterial hypotension and metabolic acidosis. Looking for the reason of her hemodynamic instability, intraoperative transthoracic echocardiography was performed, finding out the presence of pericardial effusion. Once the cardiac surgeon extracted pericardial clots, patient's situation improved clinically and analytically.Conclusion
Every anesthesiologist should be able to use the intraoperative echocardiography as an effective tool in order to establish the appropriate measures to promote the survival of patients suffering severe trauma. 相似文献Introduction
The fast track / ultra-fast-track protocols are techniques used to optimise the patient care process and a quick recovery after cardiac surgery. They are one of the mainstays of efficient practice. With their use, the length of hospital and intensive care unit (ICU) stays are reduced, with a direct impact on costs and the quality of the health service.Objective
To compare the length of stay in the ICU, length of hospital stay, and post-operative mortality in ultra-fast-track extubated (uFTE) patients and those with conventional extubation (CE) after cardiac surgery.Methods
Longitudinal, analytical, retrospective study was conducted, with the period between the time of surgery and discharge being included as the study period.Results
A total of 396 patients older than 18 years who required cardiac surgery were included, of whom 207 patients had (uFTE) and 189 had CE. Although the groups were not comparable due to the statistical differences found, when performing the multivariate adjustment, uFTE maintained its statistical independence and was associated with lower cardiovascular morbidity, such as myocardial ischaemia (95% CI: 0.37-0.86; P = .01) and lower post-surgical vasopressor requirement (95% CI: 0.18-0.49; P < .01). No significant differences were found in the length of hospital stay, ICU stay, or post-operative mortality in the ICU.Conclusion
Implementing the uFTE strategy, decreases cardiovascular morbidity and vasopressor requirement. The change to uFTE should be accompanied by changes in models and practices in patient recovery to standardised protocols. This study shows that uFTE did not reduce the length of ICU stay, hospital stay, or mortality. 相似文献Areas covered: We discuss the potential mechanism supporting the contribution of visfatin to RA and the association between RA and obesity. We discuss the repurposing of cancer-tested drugs to inhibit visfatin in the context of RA. Additionally, we address the possibility of combining these drugs with current RA therapy. Finally, we explore the future of visfatin as an RA biomarker or therapeutic target.
Expert opinion: Inhibition of visfatin has become an interesting therapeutic approach for RA pathology. Such a feat has already been attained in oncology using small molecule inhibitors, which suggest that a similar course of action would be worth pursuing in the RA context. Visfatin will become an important biomarker and therapeutic target for RA. 相似文献